Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Curr Pharm Des ; 28(14): 1187-1197, 2022.
Article in English | MEDLINE | ID: mdl-35524676

ABSTRACT

BACKGROUND: Ischemic stroke produces a large health impact worldwide, with scarce therapeutic options. OBJECTIVE: This study aimed to reveal the role of NADPH oxidase and neuroinflammatory genes in the cerebral anti-ischemic effects of C-Phycocyanin (C-PC), the chief biliprotein of Spirulina platensis. METHODS: Rats with either focal cerebral ischemia/reperfusion (I/R) or acute brain hypoperfusion, received C-PC at different doses, or a vehicle, for up to 6 h post-stroke. Neurological, behavioral and histochemical parameters were assessed in I/R rats at 24 h. Cerebral gene expression and hippocampal neuron viability were evaluated in hypoperfused rats at acute (24 h) or chronic phases (30 days), respectively. A molecular docking analysis of NOX2 and C-PC-derived Phycocyanobilin (PCB) was also performed. RESULTS: C-PC, obtained with a purity of 4.342, significantly reduced the infarct volume and neurological deficit in a dose-dependent manner, and improved the exploratory activity of I/R rats. This biliprotein inhibited NOX2 expression, a crucial NADPH oxidase isoform in the brain, and the superoxide increase produced by the ischemic event. Moreover, C-PC-derived PCB showed a high binding affinity in silico with NOX2. C-PC downregulated the expression of pro-inflammatory genes (IFN-γ, IL-6, IL-17A, CD74, CCL12) and upregulated immune suppressive genes (Foxp3, IL-4, TGF-ß) in hypoperfused brain areas. This compound also decreased chronic neuronal death in the hippocampus of hypoperfused rats. CONCLUSION: These results suggest that the inhibition of cerebral NADPH oxidase and the improvement of neuroinflammation are key mechanisms mediating the neuroprotective actions of C-PC against brain ischemia.


Subject(s)
Brain Ischemia , Neuroprotective Agents , Reperfusion Injury , Animals , Brain Ischemia/drug therapy , Brain Ischemia/metabolism , Disease Models, Animal , Molecular Docking Simulation , NADPH Oxidases/metabolism , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Phycocyanin/pharmacology , Phycocyanin/therapeutic use , Rats , Reperfusion Injury/drug therapy
2.
Epilepsy Behav ; 23(3): 205-12, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22381390

ABSTRACT

In this study, we isolated the alkaloid erysothrine from the hydroalcoholic extract of flowers from E. mulungu and screened for its anticonvulsant and anxiolytic actions based on neuroethological and neurochemical experiments. Our results showed that the administration of erysothrine inhibited seizures evoked by bicuculline, PTZ, NMDA and most remarkably, kainic acid. Also, erysothrine induced an increase in the number of entries but not in the time spent in the open arms of the EPM. However, we did not notice any alterations in the light-dark choice or in the open-field tests. In preliminary neurochemistry tests, we also showed that erysothrine (0.001-10 µg/mL) did not alter the GABA or glutamate synaptossomal uptake and binding. Altogether, our results describe an alkaloid with anticonvulsant activity and mild anxiolytic activity that might be considered well tolerated as it does not alter the general behavior of the animals in the used doses.


Subject(s)
Alkaloids/therapeutic use , Anti-Anxiety Agents/therapeutic use , Anticonvulsants/therapeutic use , Anxiety/drug therapy , Erythrina/chemistry , Flowers/chemistry , Phytotherapy , Seizures/drug therapy , Alkaloids/isolation & purification , Animals , Anti-Anxiety Agents/isolation & purification , Anticonvulsants/isolation & purification , Anxiety/etiology , Convulsants/toxicity , Diazepam/therapeutic use , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drug Interactions , Exploratory Behavior/drug effects , Glutamic Acid/metabolism , Locomotion/drug effects , Male , Rats , Rats, Wistar , Seizures/chemically induced , Synaptosomes/drug effects , Tritium/metabolism , gamma-Aminobutyric Acid/metabolism
3.
Mol Pharmacol ; 72(5): 1228-37, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17646426

ABSTRACT

Previous studies have shown that a compound purified from the spider Parawixia bistriata venom stimulates the activity of glial glutamate transporters and can protect retinal tissue from ischemic damage. To understand the mechanism by which this compound enhances transport, we examined its effects on the functional properties of glutamate transporters after solubilization and reconstitution in liposomes and in transfected COS-7 cells. Here, we demonstrate in both systems that Parawixin1 promotes a direct and selective enhancement of glutamate influx by the EAAT2 transporter subtype through a mechanism that does not alter the apparent affinities for the cosubstrates glutamate or sodium. In liposomes, we observed maximal enhancement by Parawixin1 when extracellular sodium and intracellular potassium concentrations are within physiological ranges. Moreover, the compound does not enhance the reverse transport of glutamate under ionic conditions that favor efflux, when extracellular potassium is elevated and the sodium gradient is reduced, nor does it alter the exchange of glutamate in the absence of internal potassium. These observations suggest that Parawixin1 facilitates the reorientation of the potassium-bound transporter, the rate-limiting step in the transport cycle, a conclusion further supported by experiments showing that Parawixin1 does not stimulate uptake by an EAAT2 transport mutant (E405D) defective in the potassium-dependent reorientation step. Thus, Parawixin1 enhances transport through a novel mechanism targeting a step in the transport cycle distinct from substrate influx or efflux and provides a basis for the design of new drugs that act allosterically on transporters to increase glutamate clearance.


Subject(s)
Excitatory Amino Acid Transporter 2/drug effects , Glutamates/metabolism , Neuroprotective Agents/pharmacology , Spider Venoms/pharmacology , Animals , Biological Transport/drug effects , COS Cells , Chlorocebus aethiops , Dose-Response Relationship, Drug , Excitatory Amino Acid Transporter 2/genetics , Neuroprotective Agents/analysis , Sodium/metabolism , Spider Venoms/chemistry
4.
Basic Clin Pharmacol Toxicol ; 97(5): 289-95, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16236140

ABSTRACT

Several investigations demonstrate that neurotoxins isolated from venoms of spiders and wasps may exert specific and selective activity on structures of the mammalian CNS. In the present work we examine the neurological effects of the low molecular weight compounds of the denatured venom of the neotropical social wasp Polybia occidentalis in freely moving rats. Central administration of denatured venom decreased the duration of exploratory, elevation and grooming behaviours on the open field. Moreover, denatured venom inhibited convulsing action of bicuculline (ED50 57 microg/microl), picrotoxin (ED50 75 microg/microl) and kainic acid (ED50 44 microg/microl), although it was ineffective against pentylenetetrazole-induced seizures. Despite of its inhibitory activity, toxic effects on motor performance examined in the rotarod test were not found, not even in extremely high doses. Also, denatured venom moderately reduced the spontaneous locomotor activity at anticonvulsant doses. These findings may indicate that the denatured venom has anticonvulsant activity with scarce propensity to cause neurological side-effects. Further studies are necessary to isolate the active compound and establish its mechanism of action.


Subject(s)
Anticonvulsants , Behavior, Animal/drug effects , Wasp Venoms/pharmacology , Wasps/metabolism , Amino Acids/analysis , Animals , Chromatography, High Pressure Liquid , Convulsants , Female , Male , Motor Activity/drug effects , Neurotoxicity Syndromes/psychology , Postural Balance/drug effects , Protein Denaturation , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/prevention & control , Wasp Venoms/chemistry , Wasp Venoms/toxicity
5.
Toxicon ; 40(10): 1399-406, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12368110

ABSTRACT

Venom from male and female specimens of the medically most important Brazilian Ctenidae spider Phoneutria nigriventer (Keyserling, 1891) has been compared. Males showed a slightly higher venom yield (386 microg) than equal sized females (296 microg), while adult females showed nearly a three times higher venom yield (1079 microg). High-pressure liquid-chromatography analyses revealed differences in the venom composition between males and females. A single peak in HPLC (peak 11) was only detected in venom from females carrying egg-sacs, and sodium dodecyl sulfate-gel electrophoresis showed a series of high molecular weight proteins only in the male venom pool. The median lethal dose (LD(50)) in mice for female venom was 0.63 microg kg(-1) (95% confidence interval [0.54; 0.71] and 0.61 [0.56; 0.73] microg kg(-1)) for females with egg-sacs, when compared to the male venom which showed a LD(50) of 1.57 [1.46; 1.88] microg kg(-1). The venom of both sexes was also tested in insects using a termite bioassay with doses of 2, 3, 4, and 5 microg per termite. No effect was detected for the lowest dose of female venom, whereas all the other venom doses from both sexes caused a decreased paralysis time and death of the termites. Comparing the venom of both sexes, it was observed that female venom provoked a faster reaction than male venom. The results indicate that males and females of P.nigriventer have differing venom composition which lead to different effects in biological assays.


Subject(s)
Sex Characteristics , Spider Venoms/chemistry , Spider Venoms/toxicity , Spiders/physiology , Animals , Biological Assay , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Female , Injections, Intravenous , Isoptera/drug effects , Lethal Dose 50 , Male , Mice , Motor Activity/drug effects , Paralysis/chemically induced , Spider Venoms/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL